SOBI:STO
Swedish Orphan Biovitrum AB (publ)
၄၄၁.၂၀ SEK
arrow_upward
+၀.၈၇%(+၃.၈၀) 1D
အောက် ၁၅, GMT+၂ ၁၇:၂၉:၃၇ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
၄၃၇.၈၀ SEK
High
၄၄၃.၂၀ SEK
Low
၄၃၅.၄၀ SEK
Mkt. cap
ဋေ ၁.၅၈ သ
Avg. vol.
၂.၅၆ သိန်း
Volume
၂.၂၀ သိန်း
P/E ratio
၁၁၇.၈၄
52-wk high
၄၈၇.၀၀ SEK
52-wk low
၂၉၃.၆၀ SEK
EPS
၃.၇၄ SEK
Shares outstanding
၃၅.၇၆ ကုဋေ
No. of employees
၂ ထောင်
Open
၄၃၇.၈၀ SEK
High
၄၄၃.၂၀ SEK
Low
၄၃၅.၄၀ SEK
Mkt. cap
ဋေ ၁.၅၈ သ
Avg. vol.
၂.၅၆ သိန်း
Volume
၂.၂၀ သိန်း
P/E ratio
၁၁၇.၈၄
52-wk high
၄၈၇.၀၀ SEK
52-wk low
၂၉၃.၆၀ SEK
EPS
၃.၇၄ SEK
Shares outstanding
၃၅.၇၆ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
Simply Wall Street
·
ပြီးခဲ့သည့် ၈ နာရီ
Tryngolza Backing Could Be A Big Moment For Swedish Orphan Biovitrum Stock
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)